Target intelligence / Profile preview

Leukocyte esterase

Molecular classification
Enzyme
01

Overview

Leukocyte esterase is an enzyme released predominantly by neutrophils (a type of white blood cell) during immune activation at sites of infection or inflammation[1][3]. It hydrolyzes ester bonds in various substrates, and its activity serves as an indicator of the presence of leukocytes in bodily fluids, such as urine or ascitic fluid[1][3]. Leukocyte esterase testing is widely used in clinical laboratories as a rapid, non-invasive biomarker for detecting urinary tract infections, spontaneous bacterial peritonitis, and other inflammatory conditions, due to its strong correlation with leukocyte infiltration in fluids[1][3]. However, the molecular identity of "leukocyte esterase" is imprecise, as it represents a group of related ester-hydrolyzing enzymes rather than a single, specifically characterized protein or gene. As a result, leukocyte esterase is not a discrete molecular therapeutic target, receptor, or defined enzyme; instead, it is a test reagent and functional marker for white blood cell activity[1][3]. - Because "leukocyte esterase" refers to an enzymatic activity rather than a single, structurally unique molecule, it is not a drug target, receptor, or protein family—this makes the entity “not a therapeutic target” and thus is_incorrect=true for structured databases requiring specific molecular targets. - There is no defined mechanism of action or safety concern directly associated with targeting leukocyte esterase. Its clinical role is as a diagnostic biomarker for inflammation/infection, not as a molecular target for therapeutics[1][3].

Other names
White blood cell esteraseWBC esterasegranulocyte esteraseunsonicated white blood cell elastase
02

Biological functions

Immune response (indirect role as biomarker)Hydrolysis of ester bonds
03

Disease associations

InfectionInflammationUrinary tract infectionSpontaneous bacterial peritonitis
04

Safety considerations

Not applicable (not a therapeutic target)
05

Biomarkers

Pyuria (white blood cell presence in urine)General marker for leukocytes in fluid samples

Beyond the preview

Go deeper on Leukocyte esterase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leukocyte esterase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call